Annotation Detail for ALDH3A1
Basic Information Top
Gene Symbol: | ALDH3A1 ( ALDH3,ALDHIII,MGC10406 ) |
---|---|
Gene Full Name: | aldehyde dehydrogenase 3 family, member A1 |
Band: | 17p11.2 |
Quick Links | Entrez ID:218; OMIM: 100660; Uniprot ID:AL3A1_HUMAN; ENSEMBL ID: ENSG00000108602; HGNC ID: 405 |
Relate to Another Database: | SFARIGene; denovo-db |
Pathway ID | Pathway Name |
---|---|
PWY-2501 | fatty acid alpha-oxidation |
Pathway ID | Pathway Name |
---|---|
hsa00360 | Phenylalanine metabolism |
hsa00010 | Glycolysis / Gluconeogenesis |
hsa00980 | Metabolism of xenobiotics by cytochrome P450 |
hsa00982 | Drug metabolism - cytochrome P450 |
hsa00350 | Tyrosine metabolism |
hsa01100 | Metabolic pathways |
hsa00340 | Histidine metabolism |
No data |
No data |
Pathway ID | Pathway Name |
---|---|
P04372 | 5-Hydroxytryptamine degredation |
No data |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of ALDH3A1 mRNA | increases expression | 19933214 |
C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of ALDH3A1 mRNA | increases expression | 20713471 |
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of ALDH3A1 mRNA | affects expression | 21346803 |
C051750 | 2-hexenal | ALDH3A1 protein affects the metabolism of 2-hexenal | affects metabolic processing | 11306050 |
C051750 | 2-hexenal | ALDH3A1 protein results in decreased susceptibility to 2-hexenal | decreases response to substance | 11306050 |
C013166 | 2-nonenal | ALDH3A1 protein affects the metabolism of 2-nonenal | affects metabolic processing | 11306050 |
C013166 | 2-nonenal | ALDH3A1 protein results in decreased susceptibility to 2-nonenal | decreases response to substance | 11306050 |
C057348 | 2-octenal | ALDH3A1 protein affects the metabolism of 2-octenal | affects metabolic processing | 11306050 |
C057348 | 2-octenal | ALDH3A1 protein results in decreased susceptibility to 2-octenal | decreases response to substance | 11306050 |
C027576 | 4-hydroxy-2-nonenal | ALDH3A1 protein affects the susceptibility to 4-hydroxy-2-nonenal | affects response to substance | 15905174 |
C027576 | 4-hydroxy-2-nonenal | ALDH3A1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal | decreases response to substance | 11306050 |
C027576 | 4-hydroxy-2-nonenal | ALDH3A1 protein affects the metabolism of 4-hydroxy-2-nonenal | affects metabolic processing | 11018474 |
D000082 | Acetaminophen | Acetaminophen affects the expression of ALDH3A1 mRNA | affects expression | 17562736 |
D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of ALDH3A1 protein | affects expression | 20106945 |
C006446 | aldophosphamide | [ALDH3A1 protein co-treated with NADP] results in increased oxidation of aldophosphamide | affects cotreatment|increases oxidation | 10856427 |
C006446 | aldophosphamide | [ALDH3A1 protein co-treated with NAD] results in increased oxidation of aldophosphamide | affects cotreatment|increases oxidation | 10856427 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of ALDH3A1 mRNA | affects expression | 16483693 |
C015001 | arsenite | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ALDH3A1 mRNA | affects cotreatment|increases expression | 15894712 |
C015001 | arsenite | arsenite results in increased expression of ALDH3A1 mRNA | increases expression | 15894712 |
D001374 | Azacitidine | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
D001374 | Azacitidine | Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | decreases reaction|increases expression | 17682057 |
C032175 | benzaldehyde | [ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde | affects cotreatment|increases oxidation | 10856427 |
C032175 | benzaldehyde | [ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde | affects cotreatment|increases oxidation | 10856427 |
D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH3A1 mRNA | affects cotreatment|increases expression | 18164116 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA | increases expression | 20106945 |
D001564 | Benzo(a)pyrene | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of ALDH3A1 mRNA | affects cotreatment|increases expression | 15894712 |
D001564 | Benzo(a)pyrene | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
D001564 | Benzo(a)pyrene | Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | decreases reaction|increases expression | 17682057 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA | increases expression | 15894712 17682057 20713471 |
D001564 | Benzo(a)pyrene | Butyrates inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | decreases reaction|increases expression | 17682057 |
D001564 | Benzo(a)pyrene | Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA] | decreases reaction|increases expression | 17682057 |
C006780 | bisphenol A | bisphenol A affects the expression of ALDH3A1 mRNA | affects expression | 20170705 |
D002087 | Butyrates | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
D002087 | Butyrates | Butyrates inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | decreases reaction|increases expression | 17682057 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of ALDH3A1 mRNA | increases expression | 18178546 |
D002857 | Chromium | [Azacitidine co-treated with Butyrates] inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 17682057 |
D002857 | Chromium | Azacitidine inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | decreases reaction|increases expression | 17682057 |
D002857 | Chromium | Butyrates inhibits the reaction [Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA]] | decreases reaction|increases expression | 17682057 |
D002857 | Chromium | Chromium inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA] | decreases reaction|increases expression | 17682057 |
D009243 | NAD | [ALDH3A1 protein co-treated with NAD] results in increased oxidation of aldophosphamide | affects cotreatment|increases oxidation | 10856427 |
D009243 | NAD | [ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde | affects cotreatment|increases oxidation | 10856427 |
D009249 | NADP | [ALDH3A1 protein co-treated with NADP] results in increased oxidation of aldophosphamide | affects cotreatment|increases oxidation | 10856427 |
D009249 | NADP | [ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde | affects cotreatment|increases oxidation | 10856427 |
D003520 | Cyclophosphamide | ALDH3A1 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 18854779 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of ALDH3A1 mRNA | decreases expression | 20106945 |
D016190 | Carboplatin | ALDH3A1 protein affects the susceptibility to Carboplatin | affects response to substance | 18854779 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of ALDH3A1 mRNA | increases expression | 18042831 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALDH3A1 mRNA | affects cotreatment|increases expression | 18164116 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of ALDH3A1 mRNA | increases expression | 19638242 |
D004221 | Disulfiram | ALDH3A1 protein results in increased metabolism of Disulfiram | increases metabolic processing | 18591790 |
D004050 | Ditiocarb | ALDH3A1 protein results in increased chemical synthesis of Ditiocarb | increases chemical synthesis | 18591790 |
D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALDH3A1 mRNA | affects cotreatment|increases expression | 19619570 |
D004958 | Estradiol | Estradiol results in increased expression of ALDH3A1 mRNA | increases expression | 19619570 |
D004958 | Estradiol | Estradiol promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 mRNA] | increases expression|increases reaction | 18691609 |
D000431 | Ethanol | [Ethanol co-treated with Zinc Sulfate] results in increased activity of ALDH3A1 protein | affects cotreatment|increases activity | 15920153 |
D000431 | Ethanol | Ethanol results in increased activity of ALDH3A1 protein | increases activity | 15920153 |
D005047 | Etoposide | ALDH3A1 protein affects the susceptibility to Etoposide | affects response to substance | 15905174 |
D015073 | 2-Acetylaminofluorene | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of ALDH3A1 mRNA] | affects reaction|increases expression | 17317680 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of ALDH3A1 mRNA | increases expression | 20713471 |
D020366 | Methylmethacrylate | Methylmethacrylate results in increased expression of ALDH3A1 mRNA | increases expression | 16916219 |
D016685 | Mitomycin | ALDH3A1 protein affects the susceptibility to Mitomycin | affects response to substance | 15905174 |
C010463 | n-hexanal | ALDH3A1 protein affects the metabolism of n-hexanal | affects metabolic processing | 11306050 |
C010463 | n-hexanal | ALDH3A1 protein results in decreased susceptibility to n-hexanal | decreases response to substance | 11306050 |
C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in decreased expression of ALDH3A1 mRNA | decreases expression | 17616710 |
D009853 | Omeprazole | Omeprazole results in increased expression of ALDH3A1 mRNA | increases expression | 12040753 |
C041786 | palm oil | palm oil results in increased expression of ALDH3A1 mRNA | increases expression | 18042831 |
C011272 | perfosfamide | ALDH3A1 protein results in decreased susceptibility to perfosfamide | decreases response to substance | 16614850 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ALDH3A1 mRNA | affects binding|increases activity|increases expression | 19710929 |
D011374 | Progesterone | Progesterone results in decreased expression of ALDH3A1 mRNA | decreases expression | 18037150 |
D012172 | Retinaldehyde | Retinaldehyde results in increased activity of ALDH3A1 protein | increases activity | 17126819 |
D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALDH3A1 mRNA | affects cotreatment|increases expression | 19619570 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 mRNA | increases expression | 17517823 19619570 20106945 12377990 15345368 |
D013749 | Tetrachlorodibenzodioxin | Estradiol promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 mRNA] | increases expression|increases reaction | 18691609 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 mRNA | increases expression | 18691609 19933214 10677587 15667827 16120747 16467188 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 | increases expression | 15993909 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 mRNA | increases expression | 18178546 18796159 16054898 16497791 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALDH3A1 protein | increases expression | 16497791 16548065 |
D013852 | Thiotepa | ALDH3A1 protein affects the susceptibility to Thiotepa | affects response to substance | 18854779 |
D014212 | Tretinoin | Tretinoin results in decreased activity of ALDH3A1 protein | decreases activity | 16614850 |
D014212 | Tretinoin | Tretinoin results in decreased expression of ALDH3A1 protein | decreases expression | 16614850 |
D014212 | Tretinoin | Tretinoin results in decreased expression of and results in decreased activity of ALDH3A1 protein | decreases activity|decreases expression | 15470086 |
D014752 | Vinyl Chloride | Vinyl Chloride results in increased activity of ALDH3A1 protein | increases activity | 15211785 |
D002762 | Cholecalciferol | Cholecalciferol results in increased expression of ALDH3A1 mRNA | increases expression | 17170073 |
D019287 | Zinc Sulfate | [Ethanol co-treated with Zinc Sulfate] results in increased activity of ALDH3A1 protein | affects cotreatment|increases activity | 15920153 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 11.41 | 17676605 | |
MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 11.41 | 17676605 18926900 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 11.41 | 11752688 14514962 15322242 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 14.80 | 18287403 | |
MESH:D000138 | Acidosis | Ethanol | 14.80 | 11192467 | |
MESH:D000138 | Acidosis | Zinc Sulfate | 14.80 | 7265320 | |
MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 5.04 | 9207937 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 2.63 | 18653653 | |
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 3.74 | 20127859 20464547 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 3.74 | 11473722 | |
MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 17.59 | 10737359 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 17.59 | 6695378 | |
MESH:D000236 | Adenoma | beta-Naphthoflavone | 17.59 | 19389873 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 17.59 | 10737359 6695378 | |
MESH:D000236 | Adenoma | Methylcholanthrene | 17.59 | 10545420 6695378 | |
MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 5.47 | 6705139 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 14.23 | 19052882 17620307 19061943 18056438 17162532 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 14.23 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 14.23 | 16835633 | |
MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 4.78 | 15451039 15451040 | |
MESH:D000437 | Alcoholism | Disulfiram | 4.56 | 10841824 17079463 18968458 | |
MESH:D000505 | Alopecia | Tretinoin | 3.19 | 15955085 | |
MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 3.76 | 10965797 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.49 | 11748828 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.31 | 10982225 | |
MESH:D000853 | Anophthalmos | Ethanol | 4.30 | 15513904 | |
MESH:D000860 | Anoxia | Zinc Sulfate | 4.49 | 7265320 | |
MESH:D001008 | Anxiety Disorders | Ethanol | 3.58 | 11141031 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.56 | 19183758 | |
MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 8.62 | 15014928 | |
MESH:D001161 | Arteriosclerosis | Dietary Fats | 8.62 | 15238619 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 2.74 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 2.12 | 16292516 | |
MESH:D001249 | Asthma | Tretinoin | 2.17 | 16456186 | |
MESH:D050197 | Atherosclerosis | Methylcholanthrene | 3.13 | 11922910 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 1.49 | 18445737 | |
MESH:D001327 | Autoimmune Diseases | Cholecalciferol | 4.52 | 16142846 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 3.90 | 16935849 | |
MESH:D001661 | Biliary Tract Neoplasms | Vinyl Chloride | 6.33 | 11024202 | |
MESH:D001778 | Blood Coagulation Disorders | Omeprazole | 18.10 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 18.10 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 18.10 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 18.10 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.25 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.41 | 15746008 | |
MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 4.62 | 14601052 | |
MESH:D001862 | Bone Resorption | bisphenol A | 3.39 | 11985600 | |
MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 4.80 | 17868700 | |
MESH:D001930 | Brain Injuries | Progesterone | 3.74 | 15845082 15665606 15380490 | |
MESH:D001932 | Brain Neoplasms | Vinyl Chloride | 4.72 | 12562636 | |
MESH:D001943 | Breast Neoplasms | 2,4-diaminotoluene | 11.53 | 11921183 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 11.53 | 17474063 20146248 | |
MESH:D001943 | Breast Neoplasms | bisphenol A | 11.53 | 17123778 | |
MESH:D001943 | Breast Neoplasms | Chromium | 11.53 | 15986119 | |
MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 11.53 | 11325840 17020986 18323546 15136595 18234424 16978400 17388661 15093573 12006526 | |
MESH:D001943 | Breast Neoplasms | Dietary Fats | 11.53 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 11.53 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Disulfiram | 11.53 | 17026967 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 11.53 | 17289903 16675129 17261762 18497071 19861407 17018787 12948864 14630087 | |
MESH:D001943 | Breast Neoplasms | Etoposide | 11.53 | 16322251 | |
MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 11.53 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Progesterone | 11.53 | 15562024 16175315 17614352 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 11.53 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 11.53 | 16166294 16443354 16873071 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.06 | 16813970 | |
MESH:D002056 | Burns | Ethanol | 4.14 | 16374292 | |
MESH:D002177 | Candidiasis | Disulfiram | 5.33 | 15325261 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.93 | 16111702 | |
MESH:D002277 | Carcinoma | Disulfiram | 11.72 | 17026967 | |
MESH:D002277 | Carcinoma | Methylcholanthrene | 11.72 | 10545420 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 11.72 | 16835633 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.62 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 20.50 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 20.50 | 3581430 17761372 10737359 3084413 6705139 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 20.50 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 20.50 | 12907637 12619106 21507988 | |
MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 20.50 | 19701751 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 20.50 | 16681979 18978308 18056438 19519916 20512989 11831363 18788625 16807293 19383236 20935162 19107877 18785209 16569478 20524982 19418558 17428255 16878318 16830150 20514400 16540662 17162532 19394651 18971187 16698587 17761372 20084675 18665156 17138121 20214788 19335982 17055752 19701751 16935385 18506893 10737359 19822196 19919837 18210153 20101231 19539802 10672840 3581430 20432363 21159647 18494052 20007298 20727157 16288022 16328049 17173139 18393292 19171122 19208518 16779866 16502159 17978847 18691550 19052882 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 20.50 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 20.50 | 18788625 15763234 15289165 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 20.50 | 1917145 | |
MESH:D006528 | Carcinoma, Hepatocellular | Vinyl Chloride | 20.50 | 12958735 15289165 12828392 10699891 | |
MESH:D002278 | Carcinoma in Situ | bisphenol A | 4.46 | 17123778 | |
MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 4.36 | 16152834 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 5.76 | 16685392 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 5.76 | 17026967 | |
MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 3.27 | 16201981 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 3.96 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 3.96 | 16051514 16096774 | |
MESH:D006332 | Cardiomegaly | Ethanol | 5.80 | 19332462 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 5.80 | 16120746 18670907 18850075 | |
MESH:D002386 | Cataract | Acetaminophen | 10.59 | 10977129 | |
MESH:D002386 | Cataract | Disulfiram | 10.59 | 15003327 17936468 | |
MESH:D002386 | Cataract | Tretinoin | 10.59 | 17460283 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 12.97 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 12.97 | 2727394 7505956 21159647 17174075 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 12.97 | 18566989 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 12.97 | 16192471 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 4.06 | 16129372 | |
MESH:D002637 | Chest Pain | Omeprazole | 4.57 | 15447763 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 7.84 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 7.84 | 16835633 | |
MESH:D002779 | Cholestasis | Cyclosporine | 6.44 | 19486331 | |
MESH:D002779 | Cholestasis | pirinixic acid | 6.44 | 19176532 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.62 | 16461808 | |
MESH:D002971 | Cleft Lip | Ethanol | 3.29 | 15513904 | |
MESH:D002972 | Cleft Palate | Ethanol | 8.40 | 15513904 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 8.40 | 8697196 16354765 15340226 12621046 15668235 | |
MESH:D002972 | Cleft Palate | Tretinoin | 8.40 | 9407595 | |
MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 5.22 | 19462300 | |
MESH:D003092 | Colitis | Tretinoin | 3.19 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | arsenite | 3.87 | 15037631 | |
MESH:D003110 | Colonic Neoplasms | Butyrates | 3.87 | 15936596 | |
MESH:D015179 | Colorectal Neoplasms | Azacitidine | 2.72 | 19934284 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.61 | 14669216 17141729 | |
MESH:D019465 | Craniofacial Abnormalities | Ethanol | 3.40 | 15513904 15451039 15451040 19302082 11198716 10194807 11873399 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 3.40 | 15322242 20055451 10048152 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 3.40 | 9142499 14991402 16925845 17551590 8800419 9125849 9211117 9664655 9224671 10589399 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 3.50 | 18551238 | |
MESH:D003556 | Cystitis | Cyclophosphamide | 4.45 | 15276878 11948286 12913760 10700343 18433785 18372110 10498854 16989017 18093676 16413132 15643279 12388444 16614059 18483878 17979934 12161096 18710439 18295254 17010015 16651033 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 2.16 | 18249437 | |
MESH:D009783 | Dermatitis, Occupational | Vinyl Chloride | 5.18 | 10870345 | |
MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 3.64 | 11751995 15331540 10990075 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 3.04 | 18772604 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 3.69 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 3.69 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 2.97 | 19279558 | |
MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.98 | 17187935 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 15.77 | 21346803 18551238 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 15.77 | 16081117 11739529 10915739 14550746 19739265 18713872 11287661 12392966 17522070 19370779 16109766 12153990 11421492 11461765 15968718 14725611 17906064 16485898 14986274 18071297 10774834 12540782 19923254 11529661 16227642 11743745 12958197 17562736 2444490 19416960 19420014 16781746 12594235 16393943 19085960 10663392 11834606 12705907 16177239 19164858 15619225 | |
MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 15.77 | 17851650 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 15.77 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 15.77 | 11566570 | |
MESH:D056486 | Drug-Induced Liver Injury | NAD | 15.77 | 11461765 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 15.77 | 20420201 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.56 | 19426721 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.36 | 11462148 | |
MESH:D004381 | Duodenal Ulcer | Omeprazole | 3.83 | 21218061 17151854 16613094 15991576 | |
MESH:D050171 | Dyslipidemias | Dietary Fats | 3.07 | 18367378 | |
MESH:D004487 | Edema | pirinixic acid | 5.01 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 5.01 | 11000095 12711302 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 10.15 | 18230668 16714409 15322242 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 10.15 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 3.28 | 17692515 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 6.22 | 19148513 18566989 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 6.22 | 16569247 | |
MESH:D004715 | Endometriosis | Progesterone | 7.41 | 16134523 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 7.41 | 10568697 9294722 | |
MESH:D004802 | Eosinophilia | Cyclophosphamide | 3.71 | 11006010 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.58 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 6.39 | 16530937 | |
MESH:D004938 | Esophageal Neoplasms | Ethanol | 6.39 | 16704527 | |
MESH:D004938 | Esophageal Neoplasms | nitrosobenzylmethylamine | 6.39 | 16510608 15150132 16704527 16805852 15878914 15623463 15264214 15547733 15547721 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 7.50 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 7.50 | 16938888 9664655 | |
MESH:D005234 | Fatty Liver | arsenite | 29.75 | 18296743 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 29.75 | 19224547 | |
MESH:D005234 | Fatty Liver | Dietary Fats | 29.75 | 17967931 19004024 18296743 19551842 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 29.75 | 21071580 20387270 | |
MESH:D005234 | Fatty Liver | Ethanol | 29.75 | 19236843 18620774 16409862 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 29.75 | 19236843 20131406 | |
MESH:D005234 | Fatty Liver | Vinyl Chloride | 29.75 | 12197357 | |
MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 5.13 | 17920746 | |
MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 4.77 | 16946407 15513904 10194807 15451040 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.94 | 11858732 | |
MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 4.41 | 14633661 10962813 | |
MESH:D005355 | Fibrosis | arsenite | 22.30 | 18296743 | |
MESH:D005355 | Fibrosis | Cyclosporine | 22.30 | 12639820 12168785 | |
MESH:D005355 | Fibrosis | Dietary Fats | 22.30 | 18296743 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 22.30 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 22.30 | 17994277 | |
MESH:D005756 | Gastritis | Acetaminophen | 9.34 | 16983495 | |
MESH:D005756 | Gastritis | Ethanol | 9.34 | 15046732 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.69 | 8708960 | |
MESH:D005909 | Glioblastoma | Tretinoin | 2.65 | 17312396 | |
MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.98 | 11389073 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.05 | 10696789 | |
MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 4.52 | 11014644 16376943 15172196 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 2.82 | 16096774 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.62 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 9.34 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 9.34 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 9.34 | 9664655 14991402 | |
MESH:D006333 | Heart Failure | pirinixic acid | 2.20 | 20558911 | |
MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 11.30 | 6705139 | |
MESH:D006390 | Hemangioendothelioma | Vinyl Chloride | 11.30 | 15380572 | |
MESH:D006393 | Hemangiopericytoma | Vinyl Chloride | 6.33 | 10964802 | |
MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 8.34 | 6705139 | |
MESH:D006394 | Hemangiosarcoma | Vinyl Chloride | 8.34 | 15989139 12211074 12958735 11217710 12828392 12762079 15999577 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.89 | 15720958 | |
MESH:D006467 | Hemophilia A | Cyclophosphamide | 4.77 | 11918545 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.86 | 11000095 | |
MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 4.99 | 14986274 | |
MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 4.48 | 17063115 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 6.56 | 19772884 18467677 19176532 16221962 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 6.56 | 16120746 15340226 12621046 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.49 | 15709030 | |
MESH:D006561 | Herpes Simplex | Etoposide | 4.04 | 10809021 | |
MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 6.42 | 17606976 16135485 | |
MESH:D006689 | Hodgkin Disease | Etoposide | 6.42 | 18180244 16200630 16135485 17606976 15147373 | |
MESH:D019584 | Hot Flashes | Estradiol | 3.22 | 17088409 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.51 | 15340226 18606429 8697196 16959395 16354765 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 10.64 | 16870215 | |
MESH:D006930 | Hyperalgesia | Ethanol | 10.64 | 18783367 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 10.64 | 16870215 | |
MESH:D006937 | Hypercholesterolemia | Dietary Fats | 3.12 | 21332399 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.05 | 16778211 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 2.73 | 20558911 | |
MESH:D006949 | Hyperlipidemias | Dietary Fats | 3.13 | 21332399 | |
MESH:D006973 | Hypertension | Cyclosporine | 4.19 | 10903974 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 4.19 | 18670907 18850075 | |
MESH:D007022 | Hypotension | Zinc Sulfate | 3.99 | 7265320 | |
MESH:D007154 | Immune System Diseases | Cyclophosphamide | 4.79 | 16076520 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 3.89 | 15869954 | |
MESH:D007248 | Infertility, Male | Cyclophosphamide | 3.27 | 16517039 7193160 | |
MESH:D007249 | Inflammation | Dietary Fats | 9.50 | 20412841 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 9.50 | 18785209 | |
MESH:D007249 | Inflammation | Progesterone | 9.50 | 15869954 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 9.50 | 12878042 12200463 | |
MESH:D007333 | Insulin Resistance | bisphenol A | 14.69 | 16393666 | |
MESH:D007333 | Insulin Resistance | Dietary Fats | 14.69 | 18457598 11836018 | |
MESH:D007333 | Insulin Resistance | Estradiol | 14.69 | 16393666 16627594 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 14.69 | 16306350 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 3.26 | 17994277 | |
MESH:D007569 | Jaw Abnormalities | Ethanol | 14.44 | 15513904 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 14.44 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 14.44 | 17551590 15992940 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.90 | 15604871 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 11.81 | 12587719 15629191 | |
MESH:D007674 | Kidney Diseases | Chromium | 11.81 | 17934191 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 11.81 | 10903974 8314463 18776723 | |
MESH:D007674 | Kidney Diseases | Estradiol | 11.81 | 15618244 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 14.30 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 14.30 | 12371664 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 14.30 | 15610895 | |
MESH:D007680 | Kidney Neoplasms | Vinyl Chloride | 14.30 | 12562636 | |
MESH:D007859 | Learning Disorders | Ethanol | 3.70 | 15451040 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Omeprazole | 7.44 | 19248655 | |
MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 7.44 | 15237267 | |
MESH:D007938 | Leukemia | Azacitidine | 9.01 | 19148494 | |
MESH:D007938 | Leukemia | Cyclophosphamide | 9.01 | 10602166 | |
MESH:D007938 | Leukemia | Tretinoin | 9.01 | 17143497 | |
MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 6.29 | 18587576 17658394 17296974 18172266 17008537 17802794 | |
MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 6.29 | 17026967 | |
MESH:D007945 | Leukemia, Lymphoid | Thiotepa | 5.75 | 10069464 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 7.94 | 10373061 | |
MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Thiotepa | 7.94 | 10373061 | |
MESH:D007951 | Leukemia, Myeloid | Azacitidine | 13.59 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | Thiotepa | 13.59 | 10069464 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 13.59 | 16932348 19285840 16482212 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 3.79 | 18720364 17596541 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 3.79 | 16294345 19850784 17596541 | |
MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 4.70 | 19299654 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 2.80 | 17301526 19075265 17649720 17107899 17361223 16788101 17294898 17712046 17506722 19642359 16823087 17339181 12679006 15748426 19029980 16766008 19225113 9834237 16935935 17368321 16891316 16331271 16140955 17217047 19035177 | |
MESH:D007970 | Leukopenia | Cyclophosphamide | 4.44 | 10052129 11830472 | |
MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 11.64 | 17676605 | |
MESH:D017880 | Limb Deformities, Congenital | Ethanol | 11.64 | 17676605 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 11.64 | 9224671 | |
MESH:D008103 | Liver Cirrhosis | arsenite | 17.47 | 18296743 | |
MESH:D008103 | Liver Cirrhosis | Dietary Fats | 17.47 | 18296743 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 17.47 | 18522880 19638242 18407596 18665156 20032147 | |
MESH:D008103 | Liver Cirrhosis | Ethanol | 17.47 | 15289165 | |
MESH:D008103 | Liver Cirrhosis | Vinyl Chloride | 17.47 | 15289165 11679801 12499459 12958735 15354062 | |
MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 4.57 | 18295389 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 7.62 | 14716833 14659978 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 7.62 | 18166357 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 7.62 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Retinaldehyde | 7.62 | 16248980 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 7.62 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 7.62 | 18397230 16248980 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 5.73 | 19014921 16611625 11587558 12969438 12587719 19784758 19460945 16610002 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 5.73 | 17034775 | |
MESH:D008107 | Liver Diseases | Vinyl Chloride | 5.73 | 16270392 15211785 | |
MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 4.14 | 17207112 17347304 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 2.78 | 17185352 16871587 | |
MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 25.56 | 18001218 16273603 10672840 14678523 10737359 11376686 | |
MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 25.56 | 15890375 18177683 2125692 9163691 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 25.56 | 20195826 21137059 | |
MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 25.56 | 21295105 19389873 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 25.56 | 20583210 18978307 2862719 19551842 10737359 15885732 20492335 15175105 20405173 20434301 19256749 18977376 21071580 18648771 21167192 19090486 19642983 19294768 21047994 2422723 9163691 20118626 19255062 20101389 19996281 19812893 18644402 20452335 19426721 19254457 19499222 19850985 19427195 20501860 21278145 19690152 19073162 12771043 20137499 19833225 12112319 18754104 19638242 16942905 | |
MESH:D008113 | Liver Neoplasms | Mitomycin | 25.56 | 15113037 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 25.56 | 20007298 16377806 15890375 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 25.56 | 16984957 | |
MESH:D008113 | Liver Neoplasms | Vinyl Chloride | 25.56 | 10629081 12762079 12211074 11024202 10964802 11679801 15999577 | |
MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 22.98 | 6150874 534488 1399818 | |
MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 22.98 | 8603461 | |
MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 22.98 | 18164116 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 22.98 | 17174075 19126423 21159647 18093689 17854601 18775883 16267830 9362446 19004024 16842330 18079962 18164116 19009564 18253720 19539802 18308698 2563599 3124819 18544905 19519916 17942915 18282651 | |
MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 22.98 | 598648 1399818 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 22.98 | 12151625 | |
MESH:D008114 | Liver Neoplasms, Experimental | Vinyl Chloride | 22.98 | 12562636 | |
MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 13.67 | 11376686 | |
MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 13.67 | 14755239 | |
MESH:D008175 | Lung Neoplasms | arsenite | 13.67 | 16809336 | |
MESH:D008175 | Lung Neoplasms | Azacitidine | 13.67 | 21224363 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 13.67 | 20464547 20869020 17053015 18816296 18520028 6695378 18569708 20064080 20135361 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 13.67 | 20970405 6695378 20512841 21163286 | |
MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 13.67 | 15390079 10545420 16337739 20512841 20970405 7750092 16271038 1399818 17909032 6695378 9230183 21163286 11893704 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 13.67 | 11884234 19555203 | |
MESH:D008175 | Lung Neoplasms | Vinyl Chloride | 13.67 | 12958735 12562636 | |
MESH:D008223 | Lymphoma | Cyclophosphamide | 10.72 | 12854902 | |
MESH:D008223 | Lymphoma | Etoposide | 10.72 | 12556972 12854902 | |
MESH:D008223 | Lymphoma | Thiotepa | 10.72 | 10069464 | |
MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 4.11 | 16675587 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 3.74 | 11911406 | |
MESH:D015674 | Mammary Neoplasms, Animal | Vinyl Chloride | 5.00 | 12562636 | |
MESH:D008325 | Mammary Neoplasms, Experimental | 2,4-diaminotoluene | 8.06 | 11921183 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 8.06 | 11408345 17203775 16891317 11807958 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 8.06 | 11408345 17203775 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 3.94 | 19453300 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.55 | 17453147 | |
MESH:D008545 | Melanoma | Carboplatin | 4.79 | 16225601 16342250 11712820 12040289 | |
MESH:D008545 | Melanoma | Disulfiram | 4.79 | 15367699 | |
MESH:D008545 | Melanoma | Tretinoin | 4.79 | 16752155 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 9.12 | 19513568 | |
MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 9.12 | 16388313 | |
MESH:D008569 | Memory Disorders | Ethanol | 3.69 | 18411066 15451040 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 3.91 | 16940565 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 4.25 | 16801185 | |
MESH:D009006 | Monosomy | Azacitidine | 5.54 | 19299654 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 2.78 | 16381670 | |
MESH:D009101 | Multiple Myeloma | Azacitidine | 3.59 | 18443271 19549372 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 2.99 | 16239165 | |
MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 6.64 | 18720364 17596541 19805378 17611569 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 6.64 | 17596541 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 1.91 | 19151258 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.60 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 6.89 | 16810080 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 6.89 | 16411023 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 3.33 | 18551238 | |
MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 4.81 | 18047805 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 5.48 | 3581430 9029167 | |
MESH:D009362 | Neoplasm Metastasis | Disulfiram | 5.48 | 15367699 | |
MESH:D009369 | Neoplasms | 2-hexenal | 27.26 | 10626223 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 27.26 | 11141357 | |
MESH:D009369 | Neoplasms | Carboplatin | 27.26 | 17925555 18854779 | |
MESH:D009369 | Neoplasms | Cyclophosphamide | 27.26 | 18854779 | |
MESH:D009369 | Neoplasms | Disulfiram | 27.26 | 17079463 | |
MESH:D009369 | Neoplasms | pirinixic acid | 27.26 | 17405874 | |
MESH:D009369 | Neoplasms | Thiotepa | 27.26 | 18854779 | |
MESH:D009369 | Neoplasms | Tretinoin | 27.26 | 16594593 16946489 | |
MESH:D009369 | Neoplasms | Vinyl Chloride | 27.26 | 11911487 | |
MESH:D009389 | Neovascularization, Pathologic | arsenite | 14.11 | 15738583 | |
MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 14.11 | 15367699 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 14.11 | 17289903 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.90 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 2.84 | 19348381 18481113 | |
MESH:D009421 | Nervous System Malformations | bisphenol A | 19.33 | 11399458 16427766 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 19.33 | 11399458 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 19.33 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 19.33 | 9125849 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 2.70 | 9142499 | |
MESH:D009447 | Neuroblastoma | Cyclophosphamide | 6.78 | 8761367 15176712 16115947 | |
MESH:D009447 | Neuroblastoma | Thiotepa | 6.78 | 8761367 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 6.75 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 6.75 | 20387270 | |
MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 16.36 | 12837982 | |
MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 16.36 | 8761367 12837982 | |
MESH:D017599 | Neuroectodermal Tumors | Thiotepa | 16.36 | 12837982 8761367 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.58 | 20387270 | |
MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 4.28 | 11005259 | |
MESH:D009503 | Neutropenia | Cyclophosphamide | 3.84 | 8291058 | |
MESH:D009765 | Obesity | Dietary Fats | 3.90 | 18674790 20518802 20132043 19632207 17217161 21332399 11836018 16723640 18457598 | |
MESH:D009765 | Obesity | pirinixic acid | 3.90 | 20558911 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 8.04 | 16049721 12819281 | |
MESH:D009784 | Occupational Diseases | Vinyl Chloride | 8.04 | 12061072 | |
MESH:D009845 | Oligospermia | Cyclophosphamide | 4.19 | 16517039 | |
MESH:D012516 | Osteosarcoma | Disulfiram | 4.75 | 18047805 | |
MESH:D010049 | Ovarian Diseases | bisphenol A | 4.46 | 11985600 | |
MESH:D010051 | Ovarian Neoplasms | Disulfiram | 9.73 | 17026967 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 9.73 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | Progesterone | 9.73 | 17393432 16525653 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 9.73 | 16936753 | |
MESH:D010146 | Pain | Acetaminophen | 8.82 | 16870215 | |
MESH:D010146 | Pain | Cyclophosphamide | 8.82 | 12161096 18093676 | |
MESH:D010146 | Pain | Tretinoin | 8.82 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 17.66 | 11332152 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 17.66 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Ethanol | 17.66 | 12384795 | |
MESH:D010190 | Pancreatic Neoplasms | Etoposide | 17.66 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Mitomycin | 17.66 | 15113037 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 17.66 | 15976015 | |
MESH:D010300 | Parkinson Disease | Ditiocarb | 4.10 | 11445065 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.71 | 12520081 | |
MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 4.96 | 11550810 | |
MESH:D017285 | Polymyositis | Vinyl Chloride | 6.33 | 11642524 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.06 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 7.46 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 7.46 | 2563599 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 3.49 | 21297632 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 7.76 | 10548101 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 7.76 | 11896295 11118676 11399792 11222880 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 8.98 | 20887781 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 8.98 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | Azacitidine | 2.29 | 18324645 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.29 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | bisphenol A | 2.29 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Cholecalciferol | 2.29 | 17024972 | |
MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 2.29 | 17136230 | |
MESH:D011471 | Prostatic Neoplasms | Disulfiram | 2.29 | 19789329 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 2.29 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Etoposide | 2.29 | 17172428 | |
MESH:D011507 | Proteinuria | Tretinoin | 3.12 | 16636307 | |
MESH:D011565 | Psoriasis | Cyclosporine | 2.02 | 16882103 | |
MESH:D011625 | Pterygium | Tretinoin | 4.26 | 16723453 | |
MESH:D011629 | Puberty, Precocious | bisphenol A | 4.26 | 10548101 | |
MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 3.06 | 16636934 | |
MESH:D011928 | Raynaud Disease | Vinyl Chloride | 5.61 | 16977343 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 2.11 | 19058328 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.33 | 18990726 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 3.61 | 16283617 16116481 | |
MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.65 | 18045962 | |
MESH:D012509 | Sarcoma | Vinyl Chloride | 4.89 | 12828392 | |
MESH:D012512 | Sarcoma, Ewing's | Etoposide | 4.20 | 14601052 | |
MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 10.11 | 16636934 | |
MESH:D012595 | Scleroderma, Systemic | Vinyl Chloride | 10.11 | 14979077 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 4.89 | 18551238 | |
MESH:D012640 | Seizures | Ethanol | 4.89 | 9754883 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 7.79 | 10029692 19755658 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 7.79 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 7.79 | 16467112 | |
OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.98 | 16517039 | |
MESH:D013119 | Spinal Cord Injuries | Progesterone | 3.75 | 15862959 16503802 | |
MESH:D013272 | Stomach Diseases | Omeprazole | 4.09 | 18545984 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 7.37 | 20155912 2093021 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 7.37 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Ethanol | 7.37 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | nitrosobenzylmethylamine | 7.37 | 17575124 12958204 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 7.37 | 17261132 | |
MESH:D013274 | Stomach Neoplasms | Vinyl Chloride | 7.37 | 12562636 | |
MESH:D013276 | Stomach Ulcer | Ethanol | 6.11 | 17918041 9211565 11906479 17189318 16755016 9562338 | |
MESH:D013276 | Stomach Ulcer | Omeprazole | 6.11 | 10750652 18237397 15991576 16755016 11906479 17977527 | |
MESH:D019966 | Substance-Related Disorders | bisphenol A | 3.46 | 16045194 16684133 | |
MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 3.80 | 9754883 | |
MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 17.52 | 12837982 | |
MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 17.52 | 12837982 | |
MESH:D015173 | Supratentorial Neoplasms | Thiotepa | 17.52 | 12837982 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.36 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | Butyrates | 9.76 | 17967635 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 9.76 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 9.76 | 17045167 16026305 | |
MESH:D013978 | Tibial Fractures | Estradiol | 4.15 | 19048282 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 3.33 | 16051514 | |
MESH:D014376 | Tuberculosis | Tretinoin | 2.88 | 16040207 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 10.04 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 10.04 | 15867355 1399818 15289314 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 10.04 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 10.04 | 14692829 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 3.79 | 10091137 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.50 | 10982225 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 3.22 | 16129372 | |
MESH:D014591 | Uterine Diseases | bisphenol A | 4.47 | 14652134 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 4.07 | 16752155 | |
MESH:D014605 | Uveitis | Cyclosporine | 3.45 | 1336536 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.05 | 12125929 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.56 | 16761959 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.71 | 15886252 | |
MESH:D015430 | Weight Gain | Dietary Fats | 3.29 | 16723640 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.52 | 16287080 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 3.90 | 17120751 |
Pathway ID | Pathway Name |
---|---|
KEGG:00410 | beta-Alanine metabolism |
KEGG:00982 | Drug metabolism - cytochrome P450 |
KEGG:00010 | Glycolysis / Gluconeogenesis |
KEGG:00340 | Histidine metabolism |
KEGG:01100 | Metabolic pathways |
KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 |
KEGG:00360 | Phenylalanine metabolism |
KEGG:00350 | Tyrosine metabolism |